Exact Sciences Rg
EXAS
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
08/30/2025 - 02:00:00
Bid
08/29/2025 - 21:59:59
Bid
Volume
Ask
08/29/2025 - 21:59:59
Ask
Volume
47.42
+0.47 ( +1.00% )
47.42
600
47.43
900
More information
Analysis by TheScreener
29.08.2025
Evaluation Neutral  
Interest Weak  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 15.08.2025.
Interest
  Weak
Two stars since 12.08.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 11.07.2025 at a price of 51.91.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 18.07.2025.
4wk Rel Perf
  -1.66%
 
The four-week dividend-adjusted underperformance versus SP500 is 1.66%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.25%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.72%.
Mkt Cap in $bn
  8.98
With a market capitalization >$8bn, EXACT SCIENCES CORPN is considered a large-cap stock.
G/PE Ratio
  3.01
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  31.99
The estimated PE is for the year 2027.
LT Growth
  96.14%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  36
For 1% of index variation, the stock varies on average by 0.36%.
Correlation
  0.14
Stock movements are totally independent of index variations.
Value at Risk
  12.07
The value at risk is estimated at USD 12.07. The risk is therefore 25.46%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  10.10.2012